Creative Medical Technology Holdings annual ebitda
2023
2024
Creative Medical Technology Holdings EBITDA Growth & History (CELZ)
Creative Medical Technology Holdings's calculated EBITDA was −$5.7M for fiscal 2024.
View full Creative Medical Technology Holdings company overviewCreative Medical Technology Holdings annual ebitda history
| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2024 | 2024-12-31 | −$5.7M | −$123,729 | — |
| 2023 | 2023-12-31 | −$5.6M | — | — |
Creative Medical Technology Holdings quarterly ebitda
Q3.22
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
| Fiscal quarter | Period ended | EBITDA | Change | YoY change |
|---|---|---|---|---|
| Q1 2025 | 2025-03-31 | −$1.6M | −$537,331 | — |
| Q4 2024 | 2024-12-31 | −$1.9M | −$855,312 | — |
| Q3 2024 | 2024-09-30 | −$1.1M | — | — |
| Q2 2024 | 2024-06-30 | −$1.6M | — | — |
| Q1 2024 | 2024-03-31 | −$1.1M | — | — |
| Q3 2022 | 2022-09-30 | −$1.0M | — | — |
Creative Medical Technology Holdings ebitda trends
Across the available reported history, Creative Medical Technology Holdings's ebitda decreased from −$5.6M to −$5.7M, a change of −$123,729. The latest reported quarter, Q1 2025, shows −$1.6M.
About the metric
What EBITDA means
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
Calculation and source
How TickerStat calculates EBITDA
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Creative Medical Technology Holdings filings at SEC.gov ↗